References
- [1] ICRU. Basic Aspects of High Energy Particle Interactions and Radiation Dosimetry. Bethesda, MD: International Commission on Radiation Units and Measurements, ICRU Report 28; 1978.
- [2] ICRU. Prescribing, recording and reporting photon beam therapy. Bethesda, MD: International Commission on Radiation Units and Measurements, ICRU Report 50; 1993.
- [3] Aaltonen P, Brahme A, Lax I, et al. Specification of dose delivery in radiation therapy. Recommendation by the Nordic Association of Clinical Physics (NACP). Acta Oncol. 1997;36(Suppl10):1-32.10.1080/0284186X.1997.11835454
- [4] Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys. 1997; 24(1):103-110.10.1118/1.598063
- [5] Brahme A. Which parameters of the dose distribution are best related to the radiation response of tumours and normal tissues. In: Radiation Dose in Radiotherapy from Prescription to Delivery (Proceedings of an Interregional Seminar for Europe, the Middle East and Africa, Leuven, 16-20 September 1991). IAEA TECDOC No. 734. IAEA; 1994. p. 37-58.
- [6] Niemierko A. A generalized concept of equivalent uniform dose [abstract]. Med Phys. 1999;26:1100.
- [7] Gay H, Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Med. 2007; 23(3-4):115-125.10.1016/j.ejmp.2007.07.001
- [8] Mavroidis P, Lind BK, Brahme A. Biologically effective uniform dose (D) for specification, report and comparison of dose response relations and treatment plans. Phys Med Biol. 2001;46(1):2607-2630.10.1088/0031-9155/46/10/307
- [9] Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys. 2002;52(1):224-235.10.1016/S0360-3016(01)02585-8
- [10] ICRU. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). ICRU Report 83. J ICRU. 2010;10(1):1-106.10.1093/jicru/10.1.Report83
- [11] Mrozowska M, Kukołowicz P. Relationships between various indices of doses distribution homogeneity. Rep Pract Oncol Radiother. 2015;20(4):278-283.10.1016/j.rpor.2015.03.007447712726109915
- [12] Miles EF, Nelson JW, Alkaissi AK, et al. Biologically effective dose (BED) correlation after low-dose rate prostate brachytherapy for clinically low-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2010;77(1):139-146.10.1016/j.ijrobp.2009.04.05219836161
- [13] Hartley A, Sanghera P, Kazi W, et al. Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer. Clin Oncol. 2011;23(1):29-33.10.1016/j.clon.2010.08.00720829006
- [14] Xia B, Chen GY, Cai XW, et al. The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer. Radiat Oncol. 2011;6:50.10.1186/1748-717X-6-50311770721592406
- [15] Piotrowski T, Jodda A. How to compare treatment plans? Personalized perspective. Rep Pract Oncol Radiother. 2015;20(2):77-78.10.1016/j.rpor.2014.04.011
- [16] Bentzen SM. Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol. 2005;6(2):112-117.10.1016/S1470-2045(05)01737-7
- [17] Toma-Dasu I, Dasu A. Towards Multidimensional Radiotherapy: key challenges for treatment individualisation. Comput Math Methods Med. 2015;2015:934380.10.1155/2015/934380436533925834635